CSL Earnings Slashed Amidst Vaccination Decline
CSL has significantly revised its earnings and revenue forecasts due to a decline in US vaccination rates.
This announcement coincides with the company's decision to shelve plans for the demerger of its Seqirus vaccines business.
Additionally, CSL faces a potential board spill following a second consecutive year of shareholder rejection of the company's remuneration report.
The company anticipates a 12 per cent drop in US vaccination rates during the upcoming northern hemisphere winter.
No specific quote available in the text.
Author's summary: CSL revises earnings forecasts due to declining US vaccination rates.
- Decline in US vaccination rates
- Shelving of Seqirus vaccines business demerger plans
- Potential board spill due to shareholder rejection of remuneration report
More News
- Attempted coup d'état in Benin
- No quick fix for ‘tiresome’ M50 gridlock, Minister says
- Congress gridlocked on key issues as year-end deadline looms
- Tartan Army set for ‘big bash’ in Boston with two games in New England
- Breaking: Loyalist troops foil coup attempt in Benin
- Babar Azam, Mohammad Rizwan in focus: PCB clears Big Bash NOCs for Pakistan players, but with a catch
- Another Coup In Africa, Soldiers Appear On State TV To Announce Takeover
- GRIDLOCK Definition & Meaning
- Benin coup attempt foiled by loyalist troops, interior minister says
- Commuters hot under the collar as snow, ice gridlock roads across Seoul